Loı̈c Guillevin

65.6k total citations · 7 hit papers
664 papers, 28.7k citations indexed

About

Loı̈c Guillevin is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Physiology. According to data from OpenAlex, Loı̈c Guillevin has authored 664 papers receiving a total of 28.7k indexed citations (citations by other indexed papers that have themselves been cited), including 414 papers in Pulmonary and Respiratory Medicine, 256 papers in Rheumatology and 152 papers in Physiology. Recurrent topics in Loı̈c Guillevin's work include Vasculitis and related conditions (362 papers), Sarcoidosis and Beryllium Toxicity Research (128 papers) and Systemic Sclerosis and Related Diseases (96 papers). Loı̈c Guillevin is often cited by papers focused on Vasculitis and related conditions (362 papers), Sarcoidosis and Beryllium Toxicity Research (128 papers) and Systemic Sclerosis and Related Diseases (96 papers). Loı̈c Guillevin collaborates with scholars based in France, United States and United Kingdom. Loı̈c Guillevin's co-authors include Luc Mouthon, Christian Pagnoux, Alfred Mahr, Pascal Cohen, François Lhote, B Jarrousse, David Jayne, Raphaèle Séror, Philippe Guilpain and M. Gayraud and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of Clinical Investigation.

In The Last Decade

Loı̈c Guillevin

637 papers receiving 27.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis

2007 706 citations David Jayne, Gill Gaskin et al. Journal of the American Society of Nephrology profile →
Churg-Strauss Syndrome Clinical Study and Long-Term Follow-Up of 96 Patients

1999 677 citations Loı̈c Guillevin et al. Medicine profile →
Prognostic Factors in Polyarteritis Nodosa and Churg-Strauss Syndrome A Prospective Study in 342 Patients

1996 637 citations Loı̈c Guillevin, Pascal Cohen et al. Medicine profile →
EULAR recommendations for the management of primary small and medium vessel vasculitis

2008 618 citations Loı̈c Guillevin, David Jayne et al. profile →
The Five-Factor Score Revisited

2010 580 citations Loı̈c Guillevin, Raphaèle Séror et al. Medicine profile →
Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study

2005 520 citations É. Hachulla, Loı̈c Guillevin et al. profile →
EULAR recommendations for the management of large vessel vasculitis

2008 431 citations Loı̈c Guillevin, David Jayne et al. profile →

Peers

Countries citing papers authored by Loı̈c Guillevin

Since Specialization

Citations

This map shows the geographic impact of Loı̈c Guillevin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Loı̈c Guillevin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Loı̈c Guillevin more than expected).

Fields of papers citing papers by Loı̈c Guillevin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Loı̈c Guillevin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Loı̈c Guillevin. The network helps show where Loı̈c Guillevin may publish in the future.

Co-authorship network of co-authors of Loı̈c Guillevin

This figure shows the co-authorship network connecting the top 25 collaborators of Loı̈c Guillevin. A scholar is included among the top collaborators of Loı̈c Guillevin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Loı̈c Guillevin. Loı̈c Guillevin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Risk factors for hypogammaglobulinemia and association with relapse and severe infections in ANCA-associated vasculitis: A cohort study 2023 ·Journal of Autoimmunity ·(unknown), Yann Nguyen, Jérôme Hadjadj, Pascal Cohen, Luc Mouthon, Xavier Puéchal, Loı̈c Guillevin, Benjamin Terrier	3
2	Score to assess the probability of relapse in granulomatosis with polyangiitis and microscopic polyangiitis 2023 ·RMD Open ·Maxime Samson, H. Devilliers, Sara Thietart, Pierre Charles, Christian Pagnoux, Pascal Cohen, Alexandre Karras, Luc Mouthon, Benjamin Terrier, Xavier Puéchal, Loı̈c Guillevin	6
3	Prognostic value of automated assessment of interstitial lung disease on CT in systemic sclerosis 2023 ·Lara D. Veeken ·(unknown), Trieu-Nghi Hoang-Thi, Raphaël Porcher, Bertrand Dunogué, A. Bérezné, Loı̈c Guillevin, Véronique Le Guern, Pascal Cohen, Benjamin Chaigne, Jonathan London, Matthieu Groh, Romain Paule, Guillaume Chassagnon, Maria Vakalopoulou, Anh Tuan Dinh‐Xuan, Marie‐Pierre Revel, Luc Mouthon, Alexis Régent	12
4	Bartonella and Coxiella infections presenting as systemic vasculitis: case series and review of literature 2021 ·Lara D. Veeken ·Maxime Beydon, Christophe Rodriguez, Alexandre Karras, (unknown), Cédric Rafat, Noémie Jourde‐Chiche, O. Fain, Carole Philipponnet, Xavier Puéchal, Antoine Dossier, N. Dupin, Daniel Levy, (unknown), Loı̈c Guillevin, Benjamin Terrier, (unknown)	17
5	Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitis 2020 ·Lara D. Veeken ·Jonathan London, (unknown), Sébastien Lofek, Jérémie Dion, Benjamin Chaigne, Julie Mocek, Nathalie Thiéblemont, Pascal Cohen, Claire Le Jeunne, Loı̈c Guillevin, Véronique Witko‐Sarsat, Nadine Varin‐Blank, Benjamin Terrier, Luc Mouthon, (unknown)	8
6	Cardiac Intravoxel Incoherent Motion Diffusion‐Weighted Magnetic Resonance Imaging With T1 Mapping to Assess Myocardial Perfusion and Fibrosis in Systemic Sclerosis: Association With Cardiac Events From a Prospective Cohort Study 2020 ·Arthritis & Rheumatology ·Benjamin Terrier, Agnès Dechartres, H. Gouya, (unknown), A. Bérezné, Alexis Régent, Bertrand Dunogué, Jonathan London, Pascal Cohen, Loı̈c Guillevin, Claire Le Jeunne, P. Legmann, O. Vignaux, Luc Mouthon	22
7	Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group 2019 ·Lara D. Veeken ·Antoine Lafarge, Adrien Joseph, Christian Pagnoux, Xavier Puéchal, Pascal Cohen, Maxime Samson, M. Hamidou, Alexandre Karras, T. Quéméneur, Camillo Ribi, Matthieu Groh, Luc Mouthon, Loı̈c Guillevin, Benjamin Terrier, (unknown)	14
8	Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study 2018 ·European Journal of Internal Medicine ·Maxime Samson, H. Devilliers, K.H. Ly, F. Maurier, Boris Bienvenu, Benjamin Terrier, Pierre Charles, Loı̈c Guillevin, J.-F. Besancenot, É. Liozon, A.L. Fauchais, Romaric Loffroy, Christine Binquet, Sylvain Audia, Raphaèle Séror, Xavier Mariette, Bernard Bonnotte	30
9	mTOR pathway is activated in endothelial cells from patients with Takayasu arteritis and is modulated by serum immunoglobulin G 2018 ·Lara D. Veeken ·Jérôme Hadjadj, Guillaume Canaud, Tristan Mirault, Maxime Samson, Patrick Bruneval, Alexis Régent, Claire Goulvestre, Véronique Witko‐Sarsat, N. Costedoat‐Chalumeau, Loı̈c Guillevin, Luc Mouthon, Benjamin Terrier, (unknown)	35
10	Microscopic polyangiitis and non-HBV polyarteritis nodosa with poor-prognosis factors: 10-year results of the prospective CHUSPAN trial. 2017 ·PubMed ·M. Samson, Xavier Puéchal, Luc Mouthon, H. Devilliers, Pascal Cohen, Boris Bienvenu, K.H. Ly, A Bruet, B Gilson, M. Ruivard, Édouard Pertuiset, M. Hamidou, Christian Pagnoux, Benjamin Terrier, Loı̈c Guillevin	18
11	Employment, work disability and quality of life in patients with ANCA-associated vasculitides. The EXPOVAS study. 2017 ·PubMed ·Lucas Benarous, Benjamin Terrier, Hervé Laborde‐Castérot, A. Bérezné, Bertrand Dunogué, Pascal Cohen, Xavier Puéchal, Luc Mouthon, Lynda Bensefa‐Colas, Loı̈c Guillevin	23
12	Concordance of Time-of-Flight MRA and Digital Subtraction Angiography in Adult Primary Central Nervous System Vasculitis 2017 ·American Journal of Neuroradiology ·Hubert de Boysson, Grégoire Boulouis, Jean‐Jacques Parienti, Emmanuel Touzé, Mathieu Zuber, Caroline Arquizan, Nelly Dequatre, Olivier Detante, Boris Bienvenu, Achille Aouba, Loı̈c Guillevin, Christian Pagnoux, Olivier Naggara	15
13	Which patients with rheumatoid arthritis, spondyloarthritis, or juvenile idiopathic arthritis receive TNF-α antagonists in France? The CORPUS cohort study. 2015 ·PubMed ·Alain Saraux, Jacques Bénichou, Loı̈c Guillevin, (unknown), C Job-Deslandre, Jean Sibilia, Marc Soudant, Daniel Wendling, Françis Guillemin	5
14	Pituitary Involvement in Granulomatosis With Polyangiitis 2015 ·Medicine ·(unknown), Xavier Puéchal, (unknown), Gérald Raverot, H. Gil, Laurent Pérard, G. Le Guenno, S. Berthier, (unknown), (unknown), S. Vinzio, Loı̈c Guillevin, P. Sève	47
15	Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma 2011 ·European Respiratory Journal ·Hanadi Dib, Mathieu C. Tamby, Guillaume Bussone, Alexis Régent, A. Bérezné, (unknown), Cédric Broussard, Gérald Simonneau, Loı̈c Guillevin, Véronique Witko‐Sarsat, Marc Humbert, Luc Mouthon	73
16	Pulmonary arterial hypertension associated with systemic sclerosis in patients with functional class II dyspnoea: mild symptoms but severe outcome 2010 ·Lara D. Veeken ·É. Hachulla, David Launay, A. Yaïci, A. Bérezné, Pascal de Groote, Olivier Sitbon, Luc Mouthon, Loı̈c Guillevin, P.Y. Hatron, Gérald Simonneau, Pierre Clerson, Marc Humbert, (unknown)	46
17	Patients' beliefs about the causes of systemic lupus erythematosus 2009 ·Lara D. Veeken ·Olivier Taïeb, (unknown), Thierry Baubet, Valérie Gaboulaud, (unknown), Luc Mouthon, R. Dhôte, Loı̈c Guillevin, Marie Rose Moro	23
18	Randomized Trial of Plasma Exchange or High-Dosage Methylprednisolone as Adjunctive Therapy for Severe Renal Vasculitis breakdown → 2007 ·Journal of the American Society of Nephrology ·David Jayne, Gill Gaskin, Niels Rasmussen, Daniel Abramowicz, Franco Ferrario, Loı̈c Guillevin, E Mirapeix, Caroline O. S. Savage, Renato Alberto Sinico, Coen A. Stegeman, Kerstin Westman, Fokko J. van der Woude, Robert A.F. de Lind van Wijngaarden, Charles D. Pusey	706
19	Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. 2001 ·PubMed ·Bruno Fautrel, G Le Moël, B. Saint-Marcoux, Pierre Taupin, S. Vignes, Serge Rozenberg, A C Koeger, Oliver Meyer, Loı̈c Guillevin, J.C. Piette, Pierre Bourgeois	212
20	Maladie de Takayasu à localisation artérielle pulmonaire exclusive. 1989 ·Revue de Pneumologie Clinique ·(unknown), (unknown), Loı̈c Guillevin, Jean‐Sebastien G. Bouillard, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact